Literature DB >> 32234090

Diet and liver cancer risk: a narrative review of epidemiological evidence.

Wan-Shui Yang1, Xu-Fen Zeng1, Zhi-Ning Liu2, Qi-Hong Zhao1, Yu-Ting Tan3, Jing Gao3, Hong-Lan Li3, Yong-Bing Xiang3.   

Abstract

Primary liver cancer is the third leading cause of cancer-related death worldwide. Most patients are diagnosed at late stages with poor prognosis; thus, identification of modifiable risk factors for primary prevention of liver cancer is urgently needed. The well-established risk factors of liver cancer include chronic infection with hepatitis B virus (HBV) or hepatitis C virus (HCV), heavy alcohol consumption, metabolic diseases such as obesity and diabetes, and aflatoxin exposure. However, a large proportion of cancer cases worldwide cannot be explained by current known risk factors. Dietary factors have been suspected as important, but dietary aetiology of liver cancer remains poorly understood. In this review, we summarised and evaluated the observational studies of diet including single nutrients, food and food groups, as well as dietary patterns with the risk of developing liver cancer. Although there are large knowledge gaps between diet and liver cancer risk, current epidemiological evidence supports an important role of diet in liver cancer development. For example, exposure to aflatoxin, heavy alcohol drinking and possibly dairy product (not including yogurt) intake increase, while intake of coffee, fish and tea, light-to-moderate alcohol drinking and several healthy dietary patterns (e.g. Alternative Healthy Eating Index) may decrease liver cancer risk. Future studies with large sample size and accurate diet measurement are warranted and need to consider issues such as the possible aetiological heterogeneity between liver cancer subtypes, the influence of chronic HBV or HCV infection, the high-risk populations (e.g. cirrhosis) and a potential interplay with host gut microbiota or genetic variations.

Entities:  

Keywords:  Diet; Epidemiology; Hepatocellular carcinoma; Liver cancer; Nutrition

Year:  2020        PMID: 32234090     DOI: 10.1017/S0007114520001208

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  26 in total

1.  Clinical and prognostic value of CT perfusion imaging parameters in patients with primary liver cancer after therapy.

Authors:  Yiming Li; Yuzhou Li; Yuan Sui; Guangyao Lin; Wenqi Huang; Yinshi Zheng
Journal:  Am J Transl Res       Date:  2022-01-15       Impact factor: 4.060

Review 2.  Understanding the Role of Metabolic Syndrome as a Risk Factor for Hepatocellular Carcinoma.

Authors:  Norberto C Chavez-Tapia; Sofía Murúa-Beltrán Gall; Ana Luisa Ordoñez-Vázquez; Natalia Nuño-Lambarri; Paulina Vidal-Cevallos; Misael Uribe
Journal:  J Hepatocell Carcinoma       Date:  2022-07-05

3.  MVI-Mind: A Novel Deep-Learning Strategy Using Computed Tomography (CT)-Based Radiomics for End-to-End High Efficiency Prediction of Microvascular Invasion in Hepatocellular Carcinoma.

Authors:  Liyang Wang; Meilong Wu; Rui Li; Xiaolei Xu; Chengzhan Zhu; Xiaobin Feng
Journal:  Cancers (Basel)       Date:  2022-06-15       Impact factor: 6.575

4.  Identification of the fatty acid synthase interaction network via iTRAQ-based proteomics indicates the potential molecular mechanisms of liver cancer metastasis.

Authors:  Juan Huang; Yao Tang; Xiaoqin Zou; Yi Lu; Sha She; Wenyue Zhang; Hong Ren; Yixuan Yang; Huaidong Hu
Journal:  Cancer Cell Int       Date:  2020-07-21       Impact factor: 5.722

5.  Dietary fat intake and liver cancer incidence: A population-based cohort study in Chinese men.

Authors:  Xiao-Wei Ji; Jing Wang; Qiu-Ming Shen; Zhuo-Ying Li; Yu-Fei Jiang; Da-Ke Liu; Yu-Ting Tan; Hong-Lan Li; Yong-Bing Xiang
Journal:  Int J Cancer       Date:  2021-03-03       Impact factor: 7.396

6.  Severe liver fibrosis in the HCV cure era: Major effects of social vulnerability, diabetes, and unhealthy behaviors.

Authors:  Patrizia Carrieri; Fabrice Carrat; Vincent Di Beo; Marc Bourlière; Tangui Barré; Victor De Ledinghen; Georges-Philippe Pageaux; Morgane Bureau; Carole Cagnot; Céline Dorival; Elisabeth Delarocque-Astagneau; Fabienne Marcellin; Stanislas Pol; Hélène Fontaine; Camelia Protopopescu
Journal:  JHEP Rep       Date:  2022-03-30

7.  The Association between Diet and Hepatocellular Carcinoma: A Systematic Review.

Authors:  Elena S George; Surbhi Sood; Anna Broughton; Georgia Cogan; Megan Hickey; Wai San Chan; Sonal Sudan; Amanda J Nicoll
Journal:  Nutrients       Date:  2021-01-08       Impact factor: 5.717

8.  Relationship between maximum occlusal force and gastrointestinal cancer in community-dwelling older Japanese adults.

Authors:  Takamasa Komiyama; Takashi Ohi; Wakana Ito; Yoshitada Miyoshi; Takako Hiratsuka; Sanae Matsuyama; Ichiro Tsuji; Makoto Watanabe; Yoshinori Hattori
Journal:  Sci Rep       Date:  2022-01-10       Impact factor: 4.379

Review 9.  Toward improving androgen receptor-targeted therapies in male-dominant hepatocellular carcinoma.

Authors:  Hong Zhang; Kristen Spencer; Stephen K Burley; X F Steven Zheng
Journal:  Drug Discov Today       Date:  2021-02-06       Impact factor: 8.369

Review 10.  The Gut Barrier, Intestinal Microbiota, and Liver Disease: Molecular Mechanisms and Strategies to Manage.

Authors:  Julio Plaza-Díaz; Patricio Solís-Urra; Fernando Rodríguez-Rodríguez; Jorge Olivares-Arancibia; Miguel Navarro-Oliveros; Francisco Abadía-Molina; Ana I Álvarez-Mercado
Journal:  Int J Mol Sci       Date:  2020-11-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.